Next Article in Journal
Could −79 °C Spray-Type Cryotherapy Be an Effective Monotherapy for the Treatment of Keloid?
Next Article in Special Issue
Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease
Previous Article in Journal
Role of Vitamin D in Maintaining Renal Epithelial Barrier Function in Uremic Conditions
Previous Article in Special Issue
Chronic Venous Insufficiency: Transforming Growth Factor-β Isoforms and Soluble Endoglin Concentration in Different States of Wound Healing
Review

TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology

1
Norfolk and Norwich University Hospital, Colney Ln, Norwich NR47UY, UK
2
Faculty of Health Sciences, CICS-UBI—Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6201-506 Covilhã, Portugal
3
Department of General Surgery (C), Coimbra University Hospital Centre, Portugal; Faculty of Medicine, University of Coimbra, Praceta Prof. Mota Pinto, 3000-075 Coimbra, Portugal
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(12), 2534; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18122534
Received: 14 October 2017 / Revised: 21 November 2017 / Accepted: 22 November 2017 / Published: 26 November 2017
(This article belongs to the Special Issue Molecular Research on Chronic Venous Disease)
Chronic venous insufficiency and varicose veins occur commonly in affluent countries and are a socioeconomic burden. However, there remains a relative lack of knowledge about venous pathophysiology. Various theories have been suggested, yet the molecular sequence of events is poorly understood. Transforming growth factor-beta one (TGF-β1) is a highly complex polypeptide with multifunctional properties that has an active role during embryonic development, in adult organ physiology and in the pathophysiology of major diseases, including cancer and various autoimmune, fibrotic and cardiovascular diseases. Therefore, an emphasis on understanding its signaling pathways (and possible disruptions) will be an essential requirement for a better comprehension and management of specific diseases. This review aims at shedding more light on venous pathophysiology by describing the TGF-β1 structure, function, activation and signaling, and providing an overview of how this growth factor and disturbances in its signaling pathway may contribute to specific pathological processes concerning the vessel wall which, in turn, may have a role in chronic venous insufficiency. View Full-Text
Keywords: chronic venous insufficiency; growth factors; signal transduction; TGF-β1; inflammation chronic venous insufficiency; growth factors; signal transduction; TGF-β1; inflammation
Show Figures

Figure 1

MDPI and ACS Style

Serralheiro, P.; Soares, A.; Costa Almeida, C.M.; Verde, I. TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology. Int. J. Mol. Sci. 2017, 18, 2534. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18122534

AMA Style

Serralheiro P, Soares A, Costa Almeida CM, Verde I. TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology. International Journal of Molecular Sciences. 2017; 18(12):2534. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18122534

Chicago/Turabian Style

Serralheiro, Pedro, Andreia Soares, Carlos M. Costa Almeida, and Ignacio Verde. 2017. "TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology" International Journal of Molecular Sciences 18, no. 12: 2534. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18122534

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop